Edwards Lifesciences Q3 Adj. EPS $0.80 Beats $0.74 Estimate, Sales $1.716B Beat $1.676B Estimate
Benzinga Newsdesk 2 weeks ago
NewsEarningsHotEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.74 by 8.11 percent. This is a 19.4 percent increase over earnings of $0.67 per share from the
Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.74 by 8.11 percent. This is a 19.4 percent increase over earnings of $0.67 per share from the same period last year. The company reported quarterly sales of $1.716 billion which beat the analyst consensus estimate of $1.676 billion by 2.38 percent. This is a 10.50 percent increase over sales of $1.553 billion the same period last year.
